These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33573372)

  • 21. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma.
    Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD
    Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alginate-based artificial antigen presenting cells expand functional CD8
    Omotoso MO; Est-Witte SE; Shannon SR; Li S; Nair NM; Neshat SY; Kang SS; Tzeng SY; Green JJ; Schneck JP
    Biomaterials; 2025 Feb; 313():122773. PubMed ID: 39217794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
    Butler MO; Lee JS; Ansén S; Neuberg D; Hodi FS; Murray AP; Drury L; Berezovskaya A; Mulligan RC; Nadler LM; Hirano N
    Clin Cancer Res; 2007 Mar; 13(6):1857-67. PubMed ID: 17363542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles.
    Neshat SY; Bauer SJ; Rhodes KR; Quiroz VM; Wong VW; Lowmaster SM; Tzeng SY; Green JJ; Doloff JC
    ACS Biomater Sci Eng; 2023 Jun; 9(6):3522-3534. PubMed ID: 37233985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.
    Ben-Akiva E; Hickey JW; Meyer RA; Isser A; Shannon SR; Livingston NK; Rhodes KR; Kosmides AK; Warren TR; Tzeng SY; Schneck JP; Green JJ
    Acta Biomater; 2023 Apr; 160():187-197. PubMed ID: 36812956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.
    Hou F; Guo Z; Ho MT; Hui Y; Zhao CX
    ACS Nano; 2024 Mar; 18(12):8571-8599. PubMed ID: 38483840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.
    Ye Q; Loisiou M; Levine BL; Suhoski MM; Riley JL; June CH; Coukos G; Powell DJ
    J Transl Med; 2011 Aug; 9():131. PubMed ID: 21827675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.
    Koerner J; Horvath D; Herrmann VL; MacKerracher A; Gander B; Yagita H; Rohayem J; Groettrup M
    Nat Commun; 2021 May; 12(1):2935. PubMed ID: 34006895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy.
    Sun L; Shen F; Xiong Z; Yang H; Dong Z; Xiang J; Gu Q; Ji Q; Fan C; Liu Z
    J Am Chem Soc; 2022 May; 144(17):7634-7645. PubMed ID: 35438987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
    East JE; Sun W; Webb TJ
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive platform for ex vivo T-cell expansion based on biodegradable polymeric artificial antigen-presenting cells.
    Steenblock ER; Fahmy TM
    Mol Ther; 2008 Apr; 16(4):765-72. PubMed ID: 18334990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 35. Nanoparticle-based modulation of CD4
    Isser A; Silver AB; Pruitt HC; Mass M; Elias EH; Aihara G; Kang SS; Bachmann N; Chen YY; Leonard EK; Bieler JG; Chaisawangwong W; Choy J; Shannon SR; Gerecht S; Weber JS; Spangler JB; Schneck JP
    Nat Commun; 2022 Oct; 13(1):6086. PubMed ID: 36241639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response.
    Lu X; Jiang X; Liu R; Zhao H; Liang Z
    Cancer Lett; 2008 Nov; 271(1):129-39. PubMed ID: 18621475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing Dendritic Cells for Poly (D,L-lactide-
    Koerner J; Horvath D; Groettrup M
    Front Immunol; 2019; 10():707. PubMed ID: 31024545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
    PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy.
    Sun X; Han X; Xu L; Gao M; Xu J; Yang R; Liu Z
    Small; 2017 Oct; 13(40):. PubMed ID: 28861943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
    Li H; Shao S; Cai J; Burner D; Lu L; Chen Q; Minev B; Ma W
    Immunology; 2017 Nov; 152(3):462-471. PubMed ID: 28664991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.